Institutional Ownership
Dogwood Therapeutics Inc
CUSIP 92829J203COM NEWDWTXQ1 2026
13D / 13G Filings
5
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
83.0%
Max % of class reported
Institutional Holders
11
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
5 filings · latest Nov 25, 2025
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Armistice Capital, LLC | 3.28M | $6.92M |
| 2 | Geode Capital Management, LLC | 79.4K | $167.6K |
| 3 | Northern Trust Corp | 23.8K | $50.2K |
| 4 | Goldman Sachs Group Inc | 14.6K | $30.8K |
| 5 | Marshall Wace, LLP | 11.8K | $24.8K |
| 6 | Tower Research Capital LLC (Trc) | 8.1K | $17.0K |
| 7 | Ubs Group AG | 7.1K | $14.9K |
| 8 | Activest Wealth Management | 120 | $253 |
| 9 | Blackrock, Inc. | 30 | $63 |
| 10 | Group One Trading LLC | 9 | $19 |